Pharmaceutical Affairs Act Article 41
To enhance the standards of the pharmaceutical manufacturing industry and the quality of clinical trials, as well as to promote the research and development of pharmaceutical technology, the central competent health authority shall commission professional medical organizations annually to conduct educational training and cultivate talents for clinical trials.The research and development of emerging pharmaceutical technology may be rewarded by the central competent health authority and the central competent industry authority.The required qualifications, reviewing procedures, and other matters to be followed for the rewards under the preceding paragraph shall be established by the central competent health authority and the central competent industry authority.
中文原文 藥事法第41條
為提昇藥物製造工業水準與臨床試驗品質,對於藥物科技之研究發展,中央衛生主管機關每年應委託專業醫療團體辦理教育訓練,培育臨床試驗人才。
新興藥物科技之研究發展,得由中央衛生主管機關會同中央工業主管機關獎勵之。
前項獎勵之資格條件、審議程序及其他應遵行事項之辦法,由中央衛生主管機關會同中央工業主管機關定之。
新興藥物科技之研究發展,得由中央衛生主管機關會同中央工業主管機關獎勵之。
前項獎勵之資格條件、審議程序及其他應遵行事項之辦法,由中央衛生主管機關會同中央工業主管機關定之。